Literature DB >> 26196041

Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone.

Akio Fujisawa1, Yorihiro Yamamoto1.   

Abstract

OBJECTIVES: 3-Methyl-1-phenyl-2-pyrazolin-5-one (edaravone) is used in clinical treatment of acute brain infarction to rescue the penumbra, based on its ability to prevent lipid peroxidation by scavenging lipid peroxyl radicals. Here, we show that edaravone also reacts with peroxynitrite to yield 4-NO-edaravone as the major product and 4-NO2-edaravone as a minor product.
RESULTS: We observed little formation of 3-methyl-1-phenyl-2-pyrazolin-4,5-dione (4-oxoedaravone) and its hydrate, 2-oxo-3-(phenylhydrazono)butanoic acid, which are the major free radical-induced oxidation products of edaravone, suggesting that free radicals are not involved in the reaction with peroxynitrite. The reaction of peroxynitrite with edaravone is approximately 30-fold greater than with uric acid, a physiological peroxynitrite scavenger (reaction rate k = 1.5 × 10 (4)  M(-1) s(-1) vs. 480 M(-1) s(-1)). DISCUSSION: These results suggest that edaravone functions therapeutically as a scavenger of peroxynitrite as well as lipid peroxyl radicals, which is consistent with a report that edaravone treatment reduced levels of 3-nitrotyrosine in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Entities:  

Keywords:  4-NO-edaravone; 4-NO2-edaravone; Edaravone; Peroxynitrite; Uric acid

Mesh:

Substances:

Year:  2016        PMID: 26196041      PMCID: PMC6837651          DOI: 10.1179/1351000215Y.0000000025

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  28 in total

Review 1.  Altered uric acid levels and disease states.

Authors:  Melinda K Kutzing; Bonnie L Firestein
Journal:  J Pharmacol Exp Ther       Date:  2007-09-21       Impact factor: 4.030

Review 2.  Free radicals in central nervous system ischemia.

Authors:  J W Schmidley
Journal:  Stroke       Date:  1990-07       Impact factor: 7.914

3.  Effect of uric acid on liver injury during hemorrhagic shock.

Authors:  K Tsukada; T Hasegawa; S Tsutsumi; H Katoh; H Kuwano; T Miyazaki; Y Yamamoto
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

4.  Peroxynitrite-mediated oxidative modifications of complex II: relevance in myocardial infarction.

Authors:  Liwen Zhang; Chwen-Lih Chen; Patrick T Kang; Vivek Garg; Keli Hu; Kari B Green-Church; Yeong-Renn Chen
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

5.  Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.

Authors:  Ning Zhang; Miki Komine-Kobayashi; Ryota Tanaka; Meizi Liu; Yoshikuni Mizuno; Takao Urabe
Journal:  Stroke       Date:  2005-09-15       Impact factor: 7.914

6.  Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation.

Authors:  C X Santos; E I Anjos; O Augusto
Journal:  Arch Biochem Biophys       Date:  1999-12-15       Impact factor: 4.013

7.  Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study).

Authors:  Hiide Yoshino; Akio Kimura
Journal:  Amyotroph Lateral Scler       Date:  2006-12

Review 8.  Reactive oxygen species and the central nervous system.

Authors:  B Halliwell
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

Review 9.  Peroxynitrite, a stealthy biological oxidant.

Authors:  Rafael Radi
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

10.  Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?

Authors:  D Keizman; M Ish-Shalom; S Berliner; N Maimon; Y Vered; I Artamonov; J Tsehori; B Nefussy; V E Drory
Journal:  J Neurol Sci       Date:  2009-06-24       Impact factor: 3.181

View more
  11 in total

1.  Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration.

Authors:  Midori Nagase; Yorihiro Yamamoto; Yusuke Miyazaki; Hiide Yoshino
Journal:  Redox Rep       Date:  2016-02-25       Impact factor: 4.412

2.  Edaravone, a scavenger for multiple reactive oxygen species, reacts with singlet oxygen to yield 2-oxo-3-(phenylhydrazono)-butanoic acid.

Authors:  Sakiko Amekura; Kyouhei Shiozawa; Chihiro Kiryu; Yorihiro Yamamoto; Akio Fujisawa
Journal:  J Clin Biochem Nutr       Date:  2022-01-08       Impact factor: 3.179

Review 3.  Plasma marker of tissue oxidative damage and edaravone as a scavenger drug against peroxyl radicals and peroxynitrite.

Authors:  Yorihiro Yamamoto
Journal:  J Clin Biochem Nutr       Date:  2016-11-12       Impact factor: 3.114

4.  Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis.

Authors:  Katharine Nicholson; James Chan; Eric A Macklin; Mark Levine-Weinberg; Christopher Breen; Rachit Bakshi; Daniela L Grasso; Anne-Marie Wills; Samad Jahandideh; Albert A Taylor; Danielle Beaulieu; David L Ennist; Ovidiu Andronesi; Eva-Maria Ratai; Michael A Schwarzschild; Merit Cudkowicz; Sabrina Paganoni
Journal:  Ann Clin Transl Neurol       Date:  2018-10-22       Impact factor: 4.511

5.  Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis.

Authors:  Masamitsu Okada; Satoshi Yamashita; Hidetsugu Ueyama; Masatoshi Ishizaki; Yasushi Maeda; Yukio Ando
Journal:  eNeurologicalSci       Date:  2018-05-17

6.  Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients.

Authors:  Jin-Mo Park; Sun-Young Kim; Donghwi Park; Jin-Sung Park
Journal:  Neurol Sci       Date:  2019-08-30       Impact factor: 3.307

7.  Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone.

Authors:  Hee Jo Han; Ha Young Shin; Young-Chul Choi; Seung Min Kim; Seung Woo Kim
Journal:  Redox Rep       Date:  2022-12       Impact factor: 4.412

Review 8.  How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?

Authors:  Kazutoshi Watanabe; Masahiko Tanaka; Satoshi Yuki; Manabu Hirai; Yorihiro Yamamoto
Journal:  J Clin Biochem Nutr       Date:  2017-11-11       Impact factor: 3.114

9.  Increased oxidative stress and renal injury in patients with sepsis.

Authors:  Junko Yamaguchi; Midori Nagase; Yorihiro Yamamoto; Atsushi Sakurai; Airi Kubo; Hikaru Mitsuhashi; Masaru Matsuoka; Shingo Ihara; Kosaku Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2018-03-17       Impact factor: 3.114

10.  Edaravone reduces oxidative stress and intestinal cell apoptosis after burn through up-regulating miR-320 expression.

Authors:  Jiaxiang Ke; Xi Bian; Hu Liu; Bei Li; Ran Huo
Journal:  Mol Med       Date:  2019-12-11       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.